COVID-19 Severity: Lung-Heart Interplay.

Area of Science:

• Cardiology
• Pulmonology
• Infectious Diseases

Background:

• COVID-19, caused by SARS-CoV-2, emerged globally in late 2019, causing widespread illness and mortality.
• The virus primarily targets the pulmonary system, potentially leading to Acute Respiratory Distress Syndrome (ARDS) and lung failure.
• Co-morbidities like cardiovascular disease and diabetes are linked to increased COVID-19 severity, with myocardial injury observed even in patients without prior heart conditions.

Purpose of the Study:

• To explore the intricate relationship between lung and heart function during SARS-CoV-2 infection.
• To elucidate the mechanisms underlying the observed lung-heart crosstalk in COVID-19 patients.
• To provide insights for developing effective diagnostic and therapeutic strategies to mitigate COVID-19 severity.

Main Methods:

• This review synthesizes current scientific literature on COVID-19 pathophysiology.
• It analyzes mechanisms of pulmonary damage and secondary cardiac complications.
• The focus is on understanding the interplay between respiratory and cardiovascular systems.

Main Results:

• SARS-CoV-2 infection can trigger significant pulmonary inflammation, leading to systemic effects.
• Pulmonary damage can precipitate myocardial injury, even in individuals without pre-existing cardiovascular conditions.
• The crosstalk between lung and heart contributes to the high mortality rates observed in severe COVID-19 cases.

Conclusions:

• Understanding the lung-heart axis in COVID-19 is essential for early diagnosis and risk stratification.
• Identifying these mechanisms can guide the development of targeted treatments to reduce disease severity and mortality.
• Further research into this crosstalk may reveal novel therapeutic targets for managing severe COVID-19.